Skip to main content

Blood Group Antigens as Markers of Complement and Complement Regulatory Molecules

  • Chapter
  • 156 Accesses

Part of the book series: Blood Cell Biochemistry ((BLBI,volume 6))

Abstract

Complement is a complex system of about 20 interacting proteins which, by means of a cascade of proteolytic reactions, create fatal lesions in the membranes of microorganisms. Fragments released during complement activation attract phagocytes to the site of infection and facilitate phagocytosis. Complement receptors on phagocytes and red cells bind to the complement within immune complexes so as to expedite their removal from the circulation. Complement can be activated by the classical or alternative pathways, the former generally requiring the presence of antibody and the latter often being triggered directly by a foreign particle in the absence of antibody. For reviews on complement see Porter (1983) and Law and Reid (1988).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahearn, J. M., and Fearon, D. T., 1989, Structure and function of the complement receptors, CRI (CD35) and CR2 (CD2I), Adv. Immunol. 46: 183–219.

    Article  PubMed  CAS  Google Scholar 

  • Atkinson, J. P., Chan, A. C., Karp, D. R., Killion, C. C., Brown, R., Spinella, D., Shreffler, D. C., and Levine, R. P., 1988, Origin of the fourth component of complement related Chido and Rodgers blood group antigens. Complement 5: 65–76.

    PubMed  CAS  Google Scholar 

  • Banks, J. A., Parker, N., and Poole, J., 1992, Evidence to show that Dombrock (Do) antigens reside on the Gy’/Hy glycoprotein, Transfus. Med. 2 (Suppl. 1): 68 (abstract).

    Google Scholar 

  • Bartels, C., Zelinski, T., and Lockridge, 0., 1993, Mutation at codon 322 in the human acetylcholinesterase gene (ACHE) accounts for YT blood group polymorphism, Am. J. Hum. Genet. 52: 928936.

    Google Scholar 

  • Belt, K. T., Carroll. M. C., and Porter, R. R., 1984, The structural basis of the multiple forms of human complement component C4, Cell 36: 907–914.

    CAS  Google Scholar 

  • Bobolis, K. A., Moulds, J. J., and Telen, M. J.. 1992, Isolation of the JMH antigen on a novel phosphatidylinositol-linked human membrane protein, Blood 79: 1574–1581.

    PubMed  CAS  Google Scholar 

  • Caras, I. W., Davitz, M. A., Rhee, L., Weddell, G., Martin, D. W., Jr.. and Nussenzweig, V., 1987, Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325: 545–549.

    Article  PubMed  CAS  Google Scholar 

  • Carroll, M. C., and Alper, C. A., 1987, Polymorphism and molecular genetics of human C4, Br. Med. Bull. 43: 50–65.

    PubMed  CAS  Google Scholar 

  • Carroll, M. C., Belt, K. T., Palsdottir, A., and Porter, R. R., 1984. Structure and organization of the C4 genes, Philos. Trans. R. Soc. London Ser. B 306: 379–388.

    Article  CAS  Google Scholar 

  • Carroll, M. C., Palsdottir, A., Belt, K. T., and Porter, R. R., 1985, Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region, EMBO J. 4: 2547–2552.

    PubMed  CAS  Google Scholar 

  • Coyne, K. E., Hall, S. E., Thompson, E. S., Arce, M. A., Kinoshita, T., Fujita, T., Anstee, D. J., Rosse, W., and Lublin, D. M., 1992, Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor, J. Immunol. 149: 2906–2913.

    PubMed  CAS  Google Scholar 

  • Daniels, G., 1989, Cromer-related antigens—Blood group determinants on decay-accelerating factor, Vox Sang. 56: 205–211.

    Article  PubMed  CAS  Google Scholar 

  • Daniels, G., and Levene, C., 1990, Immunoblotting of Dr(a–) cells with antibodies to Cromer-related antigens, Vox Sang. 59: 127–128.

    Article  PubMed  CAS  Google Scholar 

  • Daniels, G. L., Tohyama, H., and Uchikawa, M., 1982, A possible null phenotype in the Cromer blood group complex, Transfusion 22: 362–363.

    Article  PubMed  CAS  Google Scholar 

  • Daniels, G. L., Green, C. A., Darr, F. W., Anderson, H., and Sistonen, P., 1987, A `new’ Cromerrelated high frequency antigen probably antithetical to WES, Vox Sang. 53: 235–238.

    Article  PubMed  CAS  Google Scholar 

  • Daniels, G. L., Okubo, Y., Yamaguchi, H., Seno, T., and Ikuta, M., 1989, UMC, another Cromerrelated blood group antigen, Transfusion 29: 794–797.

    Article  PubMed  CAS  Google Scholar 

  • Giles, C. M., 1984, A new genetic variant for Chido, Vox Sang. 46: 149–156.

    Article  PubMed  CAS  Google Scholar 

  • Giles, C. M., 1987, Three Chido determinants detected on the B5Rg-allotype of human C4: Their expression in Ch-typed donors and families, Hum. Immunol. 18: 111–122.

    Article  PubMed  CAS  Google Scholar 

  • Giles, C. M., 1988, Antigenic determinants of human C4. Rodgers and Chido, Exp. Clin. Immunogenet. 5: 99–114.

    PubMed  CAS  Google Scholar 

  • Giles, C. M., and Jones, J. W., 1987, A new antigenic determinant for C4 of relatively low frequency, Immunogenetics 26: 392–394.

    Article  PubMed  CAS  Google Scholar 

  • Giles, C. M., Huth, M. C., Wilson, T. E., Lewis, H. B. M., and Grove, G. E. B., 1965, Three examples of a new antibody, anti-Cs“, which reacts with 98% of red cell samples, Vox Sang. 10: 405–415.

    Article  PubMed  CAS  Google Scholar 

  • Giles, C. M., Gedde-Dahl, T., Jr., Robson, E. B., Thorsby, E., Olaisen, B., Amason, A., KissmeyerNielsen, F., and Schreuder, I., 1976. Rg’ (Rodgers) and the HLA region: Linkage and associations, Tissue Antigens 8: 143–149.

    PubMed  CAS  Google Scholar 

  • Giles, C. M., Hoffman, M., Moulds, M., Harris, M., and Dalmass, A.. 1987. Allo-anti-Chido in a Ch-positive patient, Vox Sang. 52: 129–133.

    Article  PubMed  CAS  Google Scholar 

  • Giles, C. M., UrinD Lambert, B.. Goetz, J., Hauptmann, G., Fielder, A. H. L., Oilier, W., Rittner, C., and Robson, T., 1988, Antigenic determinants expressed by human C4 allotypes; a study of 325 families provides evidence for the structural antigenic model, Immunogenetics 27: 442–448.

    CAS  Google Scholar 

  • Harris, J. P., Tegoli. J., Swanson, J., Fisher, N., Gavin, J., and Noades, J., 1967, A nebulous antibody responsible for cross-matching difficulties (Chido), Vox Sang. 12: 140–142.

    PubMed  CAS  Google Scholar 

  • Helgeson, M., Swanson, J., and Polesky, H. F., 1970, Knops—Helgeson (Kn“), a high-frequency erythrocyte antigen, Transfusion 10: 137–138.

    Article  PubMed  CAS  Google Scholar 

  • Hellman, U., Eggertsen, G., Lundwall. A, Engstrom, A, and Sjöquist, J., 1984, Primary sequence differences between Chido and Rodgers variants of tryptic Cod of the human complement system, FEBS Lett. 170: 254–258.

    CAS  Google Scholar 

  • Hourcade, D., Miesner, D. R., Atkinson, J. P., and Holers, V. M., 1988, Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1, J. Exp. Med. 168: 1255 1270.

    Google Scholar 

  • Hourcade, D., Holers, V. M., and Atkinson, J. P., 1989, The regulators of complement activation (RCA) gene cluster, Adv. Immunol. 45: 381–416.

    Article  PubMed  CAS  Google Scholar 

  • Klickstein, L. B., Wong, W. W., Smith, J. A., Wies, J. H., Wilson, J. G., and Fearon, D. T., 1987, Human C3b/C4b receptor (CRI). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristic of C3/C4 binding proteins, J. Exp. Med. 165: 1095–1112.

    Article  PubMed  CAS  Google Scholar 

  • Klickstein, L. B., Bartow, T. J., Miletic, V., Rabson, L. D., Smith, J. A., and Fearon, D. T., 1988, Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis, J. Exp. Med. 168: 1699–1717.

    Article  PubMed  CAS  Google Scholar 

  • Lacey, P., Laird-Fryer, B., Block, U., Lair, J., Guilbeau, L., and Moulds, J. J., 1980, A new high incidence blood group factor, SP; and its hypothetical allele, Transfusion 20: 632 (abstract).

    Google Scholar 

  • Lacey, P. A., Block, U. T., Laird-Fryer, B. J., Moulds, J. J.. Bryant, L. R., Giandelone, J. A., and Linnemeyer, D. R., 1985, Anti-Tc’, an antibody that defines a red cell antigen antithetical to Tc“, Transfusion 25: 373–376.

    CAS  Google Scholar 

  • Laird-Fryer, B., Dukes, C. V., Lawson, J., Moulds, J. J., Walker, E. M., Jr., and Glassman, A. B., 1983, Tc’ a high frequency blood group antigen, Transfusion 23: 124–127.

    Article  PubMed  CAS  Google Scholar 

  • Law, S. K. A., and Reid, K. B. M., 1988, Complement, IRL Press, Oxford.

    Google Scholar 

  • Levene, C., Hazel, N., Lavie, G., Greenberg, S., Laird-Fryer, B., and Daniels, G. L., 1984, A “new” phenotype confirming a relationship between C? and Tc“, Transfusion 24: 13–15.

    Article  PubMed  CAS  Google Scholar 

  • Levene, C., Hard, N., Kende, G., Papo, S., Bradford, M. F., and Daniels, G. L., 1987, A second Dr(a—) proposita with anti-D? and a family with Dr(a—) in 2 generations, Transfusion 27: 64–65.

    Article  PubMed  CAS  Google Scholar 

  • Lewis, M., Anstee, D. J., Bird, G. W. G., Brodheim, E., Cartron, J.-P., Contreras, M., Crookston, M. C., Dahr, W., Daniels, G. L., Engelfriet, C. P., Giles, C. M., Issitt, P. D., Jorgensen, J., Kornstad, L., Lubenko, A., Marsh, W. L., McCreary, J., Moore, B. P. L., Morel, P., Moulds, J. J., Nevanlinna, H., Nordhagen, R., Okubo, Y., Rosenfield, R. E., Rouger, P., Rubinstein, P., Salmon, C., Seidl, S., Sistonen, P., Tippett, P., Walker, R. H., Woodfield, G., and Young, Y., 1990, Blood group terminology 1990, Vox Sang. 58: 152–169.

    Article  Google Scholar 

  • Lin, R. C., Herman, J., Henry, L., and Daniels, G. L., 1988, A family showing inheritance of the Inab phenotype, Transfusion 28: 427–429.

    Article  PubMed  CAS  Google Scholar 

  • Longster, G., and Giles, C. M.. 1976, A new antibody specificity, anti-Rg’, reacting with a red cell and serum antigen, Vox Sang. 30: 175–180.

    Article  PubMed  CAS  Google Scholar 

  • Lublin, D. M., and Atkinson, J. P., 1989, Decay-accelerating factor: Biochemistry, molecular biology, and function, Annu. Rev. Immunol. 7: 35–58.

    Article  PubMed  CAS  Google Scholar 

  • Lublin, D. M., Thompson, E. S., Green, A. M., Levene, C., and Telen, M. J., 1991, Dr(a—) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants, J. Clin. Invest. 87: 1945–1952.

    Article  PubMed  CAS  Google Scholar 

  • Lublin, D. M., Mallinson, G., Reid, M. E., Poole, J., Thompson, E. S., Ferdman, B. R., Telen, M. J., Anstee, D. J., and Tanner, M. J. A., 1992, Molecular basis of reduced or absent expression of decay accelerating factor in Dr(a—) and Inab phenotypes of Cromer blood group, Transfusion 32 (Suppl.): 47S (abstract).

    Google Scholar 

  • Malian, M. T., Grimm, W., Hindley, L., Knighton, G., Moulds, M. K., and Moulds, J. J., 1980, The

    Google Scholar 

  • Hall serum: Detecting Knb, the antithetical allele to Kn., Transfusion 20: 630–631.

    Google Scholar 

  • Mallinson, G., and Tanner, M. J. A.. 1991, Studies on the molecular mechanism for DAF deficiency in two Inab phenotype individuals, Transfus. Med. 1(Suppl. 2 ): 43 (abstract).

    Google Scholar 

  • Mauff, G., Alper, C. A., Dawkins, R., Doxiadis, G., Giles, C. M., Hauptmann, G., Rittner, C., and Schneider, P. M., 1990, C4 nomenclature statement (1990), Complement Inflamm. 7: 261–268.

    PubMed  CAS  Google Scholar 

  • Medof, M. E., Lublin, D. M., Holers, V. M.. Ayers, D. J., Getty, R. R., Leykam, J. F., Atkinson, J. P., and Tykocinski, M. L., 1987, Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement, Proc. Natl. Acad. Sci. USA 84: 20072011

    Google Scholar 

  • Merry, A. H., Rawlinson, V. I., Uchikawa, M., Daha, M. R., and Sim, R. B., 1989, Studies on the sensitivity to complement-mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor), Br. J. Haematol. 73: 248–253.

    Article  PubMed  CAS  Google Scholar 

  • Middleton, J., Crookston, M. C., Falk, J. A., Robson, E. B., Cook, P. J. L., Batchelor, J. R., Bodmer, J., Ferrara, G. B., Festenstein, H., Harris, R., Kissmeyer-Nielsen, F., Lawler, S. D., Sachs, J. A., and Wolf, E., 1974, Linkage of Chido and HL-A, Tissue Antigens 4: 366–373.

    Article  PubMed  CAS  Google Scholar 

  • Molthan, L., 1983a, Expansion of the York, Cost, McCoy, Knops blood group system: The new McCoy antigens McC` and McCd, Med. Lab. Sci. 40: 113–121.

    PubMed  CAS  Google Scholar 

  • Molthan, L., 1983b, The serology of the York—Cost—McCoy—Knops red blood cell system, Am. J. Med. Technol. 49: 49–55.

    PubMed  CAS  Google Scholar 

  • Molthan, L., and Giles, C. M., 1975, A new antigen, Yk’ (York), and its relationship to Cs’ (Cost), Vox Sang. 29: 145–153.

    Article  PubMed  CAS  Google Scholar 

  • Molthan, L., and Moulds. J., 1978, A new antigen, McC’ (McCoy), and its relationship to Kn’ (Knops), Transfusion 18: 566–568.

    Article  PubMed  CAS  Google Scholar 

  • Molthan, L., and Paradis, D. J., 1987, Anti-Csb: The finding of the antibody antithetical to anti-Cs’, Med. Lab. Sci. 44: 94–96.

    PubMed  CAS  Google Scholar 

  • Moulds, J. M., Nickells, M. W., Moulds, J. J., Brown, M. C., and Atkinson, J. P., 1991, The C3b/ C4b receptor is recognized by the Knops, McCoy, Swain—Langley, and York blood group antisera, J. Exp. Med. 173: 1159–1163.

    Article  PubMed  CAS  Google Scholar 

  • Moulds, J. M., Moulds, J. J., Brown, M., and Atkinson, J. P., 1992, Antiglobulin testing for CR1related (Knops/McCoy/Swain—Langley/York) blood group antigens: Negative and weak reactions are caused by variable expression of CR1, Vox Sang. 62: 230–235.

    Article  PubMed  CAS  Google Scholar 

  • Nordhagen, R., Olaisen, B., Teisberg, P., and Gedde-Dahl, T., Jr., 1980, Association between the electrophoretically-determined C4M haplotype product and partial inhibition of anti-Ch’, J. Immunogenet. 7: 301–306.

    Article  PubMed  CAS  Google Scholar 

  • O’Neill, G. J., Yang, S. Y., and Dupont, B, 1978a, Two HLA-linked loci controlling the fourth component of complement, Proc. Nall. Acad. Sci. USA 75: 5165–5169.

    Article  Google Scholar 

  • O’Neill, G. J., Yang, S. Y., Tegoli, J., Berger, R., and Dupont, B., 1978b, Chido and Rodgers blood groups are distinct antigenic components of human complement C4, Nature 273: 668–670.

    Article  PubMed  Google Scholar 

  • Parsons, S. F., Spring, F. A., Merry, A. H., Uchikawa, M., Mallinson, G., Anstee, D. J., Rawlinson, V., and Daha, M., 1988, Evidence that Cromer-related blood group antigens are carried on decay-accelerating factor (DAF) suggests that the Inab phenotype is a novel form of DAF deficiency, 20th Congress International Society Blood Transfusion p. 116 (abstract).

    Google Scholar 

  • Petty, A. C., Daniels, G. L., Anstee, D. J., and Tippett, P. A., 1993, Use of the MAIEA technique to confirm the relationship between the Cromer antigens and decay accelerating factor, and to assign provisionally antigens to the short-consensus repeats, Vox Sang. 65: 309–315.

    Article  PubMed  CAS  Google Scholar 

  • Porter, R. R., 1983, Complement polymorphism, the major histocompatibility complex and associated diseases: A speculation, Mol. Biol. Med. 1: 161–168.

    PubMed  CAS  Google Scholar 

  • Post, T. W., Arce, M. A., Liszewski, M. K., Thompson, E. S., Atkinson, J. P., and Lublin, D. M., 1990, Structure of the gene for human complement protein decay accelerating factor, J. Immunol. 144: 740–744.

    PubMed  CAS  Google Scholar 

  • Rao, N., Ferguson, D. J., Lee, S.-F., and Telen, M. J., 1991, Identification of human erythrocyte blood group antigens on the C3b/C4b receptor, J. Immunol. 146: 3502–3507.

    PubMed  CAS  Google Scholar 

  • Raum, D., Awdeh, Z., Anderson, J., Strong, L.. Granados, J., Teran, L., Giblett, E., Yunis, E. J., and Alper, C. A., 1984, Human C4 haplotypes with duplicated C4A or C4B, Am. J. Hum. Genet. 36: 72–79.

    PubMed  CAS  Google Scholar 

  • Reid, M. E., Mallinson, G., Sim, R. B., Poole, J., Pausch, V., Merry, A. H., Liew, Y. W., and Tanner, M. J. A., 1991, Biochemical studies on red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency), Blood 78: 3291–3297.

    PubMed  CAS  Google Scholar 

  • Rolih, S. D., 1989, High-titer, low-avidity (HTLA) antibodies and antigens: A review, Transfus. Med. Rev. 3: 128–139.

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld, S. I., Ruddy, S.. and Austen, K. F., 1969, Structural polymorphism of the fourth component of human complement, J. Clin. Invest. 48: 2283–2292.

    Article  PubMed  CAS  Google Scholar 

  • Rosse, W. F., 1991, Abnormal sensitivity to complement due to abnormalities of the cell membrane, in Clinical and Basic Science Aspects of Immunohematology ( S. T. Nance, ed.), pp. 13–32, American Association of Blood Banks, Arlington, VA.

    Google Scholar 

  • Sistonen, P., Nevanlinna, H. R., Virtaranta-Knowles, K., Tuminen, I., Pirkola, A., Green, C. A., and Tippett, P., 1987, WES, a `new’ infrequent blood group antigen in Finns, Vox Sang. 52: 111–114.

    Article  PubMed  CAS  Google Scholar 

  • Spring, F. A., and Reid, M. E., 1991, Evidence that the human blood group antigens Gy’ and Hy are carried on a novel glycosylphosphatidylinositol-linked erythrocyte membrane glycoprotein, Vox Sang. 60: 53–59.

    Article  PubMed  CAS  Google Scholar 

  • Spring, F. A., Judson, P. A., Daniels, G. L., Parsons, S. F., Mallinson. G., and Anstee, D. J., 1987, A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets, Immunology 62: 307–313.

    CAS  Google Scholar 

  • Spring, F. A., Gardner, B., and Anstee, D. J., 1992, Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase, Blood 80: 2136–2141.

    PubMed  CAS  Google Scholar 

  • Stroup, M., and McCreary, J., 1975, Cr“, another high frequency blood group factor, Transfusion 15: 522 (abstract).

    Google Scholar 

  • Takeda, J., Miyata, T., Kawagoe, K., lids, Y., Endo, Y.. Fujita, T., Takahashi, M., Kitani, T. and Kinoshita, T. 1993. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73: 703–711.

    CAS  Google Scholar 

  • Tate, C. G., Uchikawa, M., Tanner, M. J. A., Judson, P. A., Parsons, S. F., Mallinson, G., and Anstee, D. J., 1989, Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype, Biochem. J. 261: 489–493.

    PubMed  CAS  Google Scholar 

  • Teisberg, P., Akesson, I., Olaisen, B., Gedde-Dahl, T., Jr., and Thorsby, E., 1976, Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6, Nature 264: 253–254.

    Article  PubMed  CAS  Google Scholar 

  • Teisberg, P., Jonassen, R., Mevâg, B., Gedde-Dahl, T., Jr., and Olaisen, B., 1988, Restriction fragment length polymorphisms of the complement component C4 loci on chromosome 6: Studies with emphasis on the determination of gene number, Ann. Hum. Genet. 52: 77–84.

    Article  PubMed  CAS  Google Scholar 

  • Telen, M. J., and Green, A. M., 1989, The Inab phenotype: Characterization of the membrane protein and complement regulatory defect, Blood 74: 437–441.

    PubMed  CAS  Google Scholar 

  • Telen, M. J., and Rosse, W. F., 1991, Phosphatidylinositol-glycan linked proteins of the erythrocyte membrane, in Molecular Immunohaematology (A. von dem Borne, ed.), Baillière’s Clin. Haematol. 4: 849–868.

    Google Scholar 

  • Telen, M. J., Hall, S. E., Green, A. M., Moulds, J. J., and Rosse, W. F., 1988, Identification of human erythrocyte blood group antigens on decay accelerating factor (DAF) and an erythrocyte phenotype negative for DAF, J. Exp. Med. 167: 93–98.

    Article  Google Scholar 

  • Telen, M. J., Rosse, W. F.. Parker. C. J., Moulds, M. K., and Moulds, J. J., 1990, Evidence that several high-frequency blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins, Blood 75: 1404–1407.

    PubMed  CAS  Google Scholar 

  • Telen, M. J., Rao, N., Thompson, E. S., and Lublin, D. M., 1992, Mapping and characterization of the Cr’ epitope of decay accelerating factor, Transfusion 32 (Suppl.): 47S (abstract).

    Google Scholar 

  • Tilley. C. A., Romans, D. G., and Crookston, M. C., 1978, Localisation of Chido and Rodgers determinants to the C4d fragment of human C4, Nature 276: 713–715.

    Article  Google Scholar 

  • Vik, D. P., Tack, B. F., and Wong, W. W., 1991, Structure of the complement receptor type 1 (CR1) gene and sequence of the S allele. Complement Inflamm. 8: 238–239 (abstract).

    Google Scholar 

  • Walthers, L., Salem, M., Tessel, J., Laird-Fryer, B., and Moulds, J. J., 1983, The Inab phenotype: Another example found. Transfusion 23: 423 (abstract).

    Google Scholar 

  • Wilson, J. G., Murphy, E. E., Wong, W. W., Klickstein, L. B., Weis, J. H., and Fearon, D. T., 1986, Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes, J. Exp. Med. 164: 50–59.

    Article  PubMed  CAS  Google Scholar 

  • Wong, W. W., Cahill, J. M., Rosen, M. D., Kennedy, C. A., Bonaccio, E. T., Morris, M. J., Wilson, J. G., Klickstein, L. B., and Fearon, D. T., 1989, Structure of the human CRI gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele, J. Exp. Med. 169: 847–863.

    Article  PubMed  CAS  Google Scholar 

  • Yu, C. Y., 1991, The complete exon—intron structure of a human complement component C4A gene. DNA sequences, polymorphisms, and linkage to the 21-hydroxylase gene, J. Immunol. 146: 1057 1066.

    Google Scholar 

  • Yu, C. Y., and Campbell, R. C.. 1987, Definitive RFLPs to distinguish between human complement C4A/C4B isotypes and the major Rodgers/Chido determinants: Application to the study of C4 null alleles, Immunogenetics 25: 383–390.

    Article  PubMed  Google Scholar 

  • Yu, C. Y., Belt, K. T., Giles, C. M., Campbell, R. D., and Porter, R. R., 1986, Structural basis of the polymorphism of human complement components C4A and C4B: Gene size, reactivity and antigenicity, EMBO J. 5: 2873–2881.

    PubMed  CAS  Google Scholar 

  • Yu, C. Y., Campbell. R. D., and Porter, R. R., 1988, A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes, Immunogenetics 27: 399–405.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Daniels, G. (1995). Blood Group Antigens as Markers of Complement and Complement Regulatory Molecules. In: Cartron, JP., Rouger, P. (eds) Molecular Basis of Human Blood Group Antigens. Blood Cell Biochemistry, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9537-0_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9537-0_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-44853-9

  • Online ISBN: 978-1-4757-9537-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics